Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/60933| Title: | Falsified medicines directive : challenges faced by small member states |
| Authors: | Almojero, Danielle Claire E. Vella Szijj, Janis Serracino-Inglott, Anthony |
| Keywords: | Drugs -- Law and legislation -- European Union countries Drugs -- Law and legislation -- Malta Pharmaceutical industry -- Malta Drug adulteration -- Law and legislation -- Malta |
| Issue Date: | 2020 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Almojero, D. C. E., Vella Szijj, J., & Serracino-Inglott, A. (2020). Falsified medicines directive : challenges faced by small member states. FIP Virtual Event : Living and Learning Through the Covid-19 Pandemic - Global Reflections. |
| Abstract: | Falsified medicines can be considered substandard in quality, formulation, labelling and/or without appropriate registration with the competent authority. The Falsified Medicines Directive (FMD) or Directive 2011/62/EU, which amended Directive 2001/83/EC, was implemented in February 2019 to decrease the use of falsified medicines. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/60933 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Almojero - Falsified Medicines Directive_ Challenges Faced by Small Member States.pdf | 291.35 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.